Irina F. Dovgalyuk

Irina F. Dovgalyuk

Auto-generated profile, based on publicly available information

Irina F. Dovgalyuk

St. Petersburg Research Institute of Phthisiopulmonology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
DKDmitry Kudlay
Dmitry Kudlay
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
IDI.F. Dovgalyuk
I.F. Dovgalyuk
JGJsc Generium
Jsc Generium
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

21 June 2020 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
EKEkaterina A. Kushnareva
Ekaterina A. Kushnareva
AMAnna Malkova
Anna Malkova
IDIrina F. Dovgalyuk
Irina F. Dovgalyuk
DKDmitry Kudlay
Dmitry Kudlay
Новая коронавирусная инфекция: особенности клинического течения, возможности диагностики, лечения и профилактики инфекции у взрослых и детей

12 August 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
DKDmitry Kudlay
Dmitry Kudlay
IDI.F. Dovgalyuk
I.F. Dovgalyuk
NBN.YU. Basantsova
N.YU. Basantsova
YZYu.S. Zinchenko
Yu.S. Zinchenko
PYP.K. Yablonsky
P.K. Yablonsky
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.

11 October 2022 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
IDI. F. Dovgalyuk
I. F. Dovgalyuk
DKDmitry Kudlay
Dmitry Kudlay
MBM. V. Beltyukov
M. V. Beltyukov
PYP. K. Yablonskiy
P. K. Yablonskiy
The epidemic situation is monitored by numerous rates that may not reflect it objectively which will subsequently lead to higher incidence rates and severe forms of tuberculosis in both adults and children in the regions with the most unfavorable situation.The objective: to evaluate epidemiological rates for tuberculosis in the Northwestern Federal District to identify the most significant, and assess the epidemic situation in the region using these most significant rates.Subjects and Methods. We analyzed the main epidemiological rates of pediatric tuberculosis according to federal statistics (Forms 8 and 33) in 11 districts of the Northwestern District in 2019-2021. Annual figures were obtained from open demographic data of the state statistics (https://www.fedstat.ru). Statistical analysis was pe`rformed using the free software R (v.3.5.1) and the commercial Statistical Package for the Social Sciences (SPSS Statistics for Windows, Version 24.0, IBM Corp., 2016). Hierarchical cluster analysis and k-means clustering were used with the selection of the lowest and highest values of rates. A formula is proposed for calculating the coefficient of full coverage with preventive screening (COP) for tuberculosis of the population which allows adjusting the analyzed epidemic rates taking into account the maximum coverage of the population with preventive screening and determining the accuracy of previous analysis.Results. According to the data obtained, in 2017 and 2018, Vologda Oblast and Nenets Autonomous Okrug were epidemically favorable regions, while in 2020 and 2021 Kaliningrad, Leningrad and Novgorod Oblasts were regarded as favorable regions that were steadily improving their performance. Regions with unfavorable tuberculosis situation include Pskov Oblast, St. Petersburg and the Komi Republic. At the same time, the first two regions occupy this position stably from 2017 to 2021. The use of the coefficient of low coverage with screening for tuberculosis made it possible to determine that Murmansk Oblast, St. Petersburg, Leningrad and Pskov Oblasts in 2020 and 2021 are prognostically unfavorable regions despite a decline in official tuberculosis rates. The data obtained correlate with a high percentage of positive tests with the tuberculosis recombinant tuberculosis allergen (TRA) in children in the regions mentioned above.Conclusions. The analysis of the data clearly demonstrates the possibility of determining the epidemically most favorable or unfavorable regions using four rates: coverage with preventive screening, incidence in the adult population, incidence in children aged 0 to 17 years, and tuberculosis mortality. Cluster analysis using these rates, calculation of rates using the developed coefficient of low coverage with screening for tuberculosis, and analysis of positive results of TRA test in children allows identifying the most epidemically unfavorable regions, despite the decrease in some rates that can be regarded as favorable.

4 August 2020 in Translational Medicine
Verified
Journal Article
Open access
PDF file
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
EKE. A. Kushnareva
E. A. Kushnareva
DKDmitry Kudlay
Dmitry Kudlay
IDI. F. Dovgalyuk
I. F. Dovgalyuk
In the context of the new coronavirus infection spreading it is particularly relevance to obtain information on the clinical course, diagnostic possibilities and features of the COVID-19 treatment. By May 2020 in the world more than 4 million people were infected by the SARS-CoV-2 virus and more than 300 thousand died. In this review data about the clinical course, diagnostic possibilities and treatment of patients with COVID-19 are present. The authors analyzed publications presented in local and international databases from December 2019 to May 2020 on the new coronavirus infection. According to the analysis the most frequent symptoms described in literature wee fever, weakness, cough, dyspnea, gastroenterological manifestation and smell dysfunction. The main methods of diagnostic are the results of clinical evaluation, computer tomography and molecular genetic methods of examination. The treatment of his infection is limited by the absence of etiological treatment and the need for symptomatic therapy. All data presented in COVID-19 treatment trials have efficacy not more than 65 %, among which lopinavir/ritonavir shows the lowest result (20 %), hydroxychloroquine and tocilizumab show better results (45 and 65 % respectively). Great hope rests on the effectiveness of immunosuppressive therapy. Moreover, all treating methods don’t reduce mortality, which is 13–22 % regardless of the treatment type.

22 March 2026 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
ASA. R. Sabirova
A. R. Sabirova
RSRaul Ахнафович Sharipov
Raul Ахнафович Sharipov
RTR. K. Tukfatullin
R. K. Tukfatullin
IDI. F. Dovgalyuk
I. F. Dovgalyuk
DKDmitry Kudlay
Dmitry Kudlay
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
The detection of latent tuberculosis infection (LTBI) is essential for improving the epidemiological situation in the region. As tuberculosis prevalence declines, identifying LTBI in risk groups becomes increasingly significant. At present, no method exists that can reliably confirm or exclude the presence of latent tuberculosis infection. In this study, we analyzed 71 publications on methods for LTBI detection, including modern immunological tests based on Mycobacterium tuberculosis antigens ESAT-6 and CFP-10, as well as interferon-γ release assays (IGRAs). Developing diagnostic strategies for LTBI is particularly relevant for individuals with diabetes mellitus, congenital or acquired immunodeficiency, those receiving immunosuppressive therapy, patients undergoing hemodialysis, as well as for children and the elderly. The search for novel LTBI biomarkers using artificial intelligence, aimed at improving detection and predicting the progression to active tuberculosis seems to be promising advancement in phthisiology.